A Closer Look at Spravato (Esketamine): How will it be administered?

9:44
 
シェア
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on January 29, 2022 09:23 (5M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 229049010 series 1756689
著作 Ketamine Wellness Centers の情報はPlayer FM及びコミュニティによって発見されました。著作権は出版社によって所持されます。そして、番組のオーディオは、その出版社のサーバから直接にストリーミングされます。Player FMで購読ボタンをタップし、更新できて、または他のポッドキャストアプリにフィードのURLを貼り付けます。
A Closer Look at Spravato (Esketamine): How will it be administered? As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode focuses on how Spravato is administered: Is intranasal delivery effective? What type of clinical environments can provide Spravato to patients? What duration of time will patients have to commit to treatment? www.ketaminewellnesscenters.com/category/podcast/

15 つのエピソード